![Liver graphic Liver graphic](/sites/default/files/2024-06/EASL%20SEO%20Teaser%20Card%20Image_1440%20x%20810px.jpg)
June 07, 2024
Results from Phase II MASH trial presented at EASL 2024
![Boehringer inhalers now available at $35 a month for eligible patients Woman with brown hair standing outside in front of blue sky](/sites/default/files/2024-05/Boehringer_Lifestyle_SocialLife_MeetingFriends_1400.jpg)
June 01, 2024
Boehringer inhalers now available at $35 a month for eligible patients
![Pharmacist talking with patient Pharmacist talking with patient](/sites/default/files/2024-05/Quallent-Announcement.jpg)
May 13, 2024
New agreement with Quallent expands biosimilar access
![Improving Access to Clinical Trials Scientists](/sites/default/files/2024-05/Boehringer_Workplace_Lab_Discussion-01_RGB_004.jpg)
May 02, 2024
Improving Access to Clinical Trials
![FDA Approves Additional Formulation of Our Biosimilar Doctor speaking with patient.](/sites/default/files/2024-04/Press%20release%20image_0.jpg)
May 01, 2024
FDA Approves Additional Formulation of Our Biosimilar
![Boehringer Ingelheim reaches more patients than ever in 2022 as innovative medicines drive growth Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline.](/sites/default/files/2024-04/boehringer_biopharmaceutical%20production_Biberach%20resized_0.jpg)
April 16, 2024
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline.
![Results announced from EMPACT-MI phase III trial Scientists working together](/sites/default/files/2024-04/Scientists_working_together.jpg)
April 06, 2024
Results announced from EMPACT-MI phase III trial
![researcher working in a lab photo of male researcher working in a lab](/sites/default/files/2024-03/Boehringer_Workplace_Lab_Research.jpg)
March 19, 2024
New FDA approval for the treatment of GPP
March 12, 2024
Update on sNDA for fibrosing ILD in children and adolescents
![Boehringer Ingelheim caps patient out-of-pocket costs for its inhaler portfolio at $35 per month Boehringer Ingelheim caps patient out-of-pocket costs for its inhaler portfolio at $35 per month](/sites/default/files/2024-03/Boehringer_Lifestyle_PhysicalActivity_ExercisingOutdoors.jpg)
March 07, 2024
Boehringer Ingelheim caps patient out-of-pocket costs for its inhaler portfolio at $35 per month
![Top-line Phase II Data for treatment of MASH Liver Illustration](/sites/default/files/2024-03/Survodutide-MASH-Phase-II-Top-Line.jpg)
February 26, 2024
Top-line Phase II Data for treatment of MASH
![photo of female physician in conversation with colleagues](/sites/default/files/us/2023-11/physician-conversation.png)
November 20, 2023